year 4, Issue 13 (2-2005)
J. Med. Plants 2005, 4(13): 45-49 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Nickavar B, Mojab F, Dolat-Abadi R. Composition of the Volatile Oil of Thymus daenensis Celak. subsp. daenensis. J. Med. Plants 2005; 4 (13) :45-49
URL: http://jmp.ir/article-1-717-en.html
URL: http://jmp.ir/article-1-717-en.html
1- Pharmaceutical Sciences Research Center, Shaheed Beheshti University of Medical Sciences, Tehran, Iran , bnickavar@yahoo.com
2- Pharmaceutical Sciences Research Center, Shaheed Beheshti University of Medical Sciences, Tehran, Iran
3- Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
2- Pharmaceutical Sciences Research Center, Shaheed Beheshti University of Medical Sciences, Tehran, Iran
3- Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
Abstract: (10439 Views)
Backgrond: Thymus daenensis Celak. subsp. daenensis is one of the endogenous Thymus species in Iran. The plant is traditionally used as carminative, digestive, antispasmodic, antitussive and expectorant in Iran. Objective: To study the Composition of the Volatile Oil of Thymus daenensis Celak. subsp. Daenensis. Method: In this study, the hydrodistilled oil of the aerial parts of T. daenensis subsp. daenensis was analyzed using GC/FID and GC/MS. The result indicates that the oil contains over twenty-six components (99.7%). The main components were thymol (74.7%), p-cymene (6.5%), β-caryophyllene (3.8%) and methyl carvacrol (3.6%). Conclusion: This species has rich in phenolic substances specially thymol which might considered as a substitute for Thymus vulgaris.
Keywords: Thymus daenensis Celak. subsp. daenensis, Essential oil, Thymol, P-cymene, β-caryophyllene, Methyl carvacrol
Type of Study: Research |
Subject:
Pharmacognosy & Pharmaceutics
Received: 2004/01/2 | Accepted: 2005/02/5 | Published: 2005/03/18
Received: 2004/01/2 | Accepted: 2005/02/5 | Published: 2005/03/18
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
